PUBLISHER: Renub Research | PRODUCT CODE: 1438327
PUBLISHER: Renub Research | PRODUCT CODE: 1438327
Genetic Testing Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
Genetic Testing Market is predicted to be priced at around US$ 37.58 Billion by 2030, according to Renub Research. In the current era, genetic testing has surged in reputation, becoming a cornerstone of customized remedies and ancestry exploration. With technological improvements and declining costs, individuals eagerly try to discover their genetic makeup, uncovering predispositions to diseases, tracing familial lineage, and making knowledgeable health decisions. The attraction of unlocking one's genetic code has captivated the public imagination, driving a cultural fascination with know-how, personal biology, and heritage. This enormous amount of genetic testing displays a societal shift towards proactive healthcare and self-discovery.
Genetic Testing Market is expected to increase at a CAGR of 9.75% during the forecast years (2024 to 2030)
The incidence of genetic diseases is gradually increasing, which is anticipated to propel the demand for genetic testing, leading to market enlargement. Genetic testing can detect diverse illnesses, including thalassemia, Down's syndrome, and cystic fibrosis. For example, as per the data posted by the United Nations on World Down Syndrome Day, about 3,000 to 5,000 children are born with Down syndrome every year.
As genetic issues become more visible and understood, humans and healthcare providers increasingly seek genetic insights to control threats and pre-emptively tailor treatments. The growing availability of genetic assessments and expanded awareness of hereditary conditions make genetic testing a crucial tool for disorder prevention and control. This anticipated surge in demand highlights the vital role genetic testing plays in the evolving healthcare panorama.
Moreover, the increasing technological improvements during the last few years have opened numerous possibilities for market growth. The upward push in the superiority of chronic illnesses and the improvement of customized testing kits for niche healing areas are assisting the genetic testing market's speedy increase. The growing R&D investment and the strong market presence of sizeable players in the global genetic testing market have created a sturdy entry barrier for brand-new entrants. Innovation in product layout, improvement in quality, and strong distribution partnerships are critical parameters for maintaining a competitive edge in the market. So, the genetic testing market was US$ 19.60 Billion in 2023.
North America is anticipated to hold the most promising proportion in the genetic testing market. This is because of the increasing incidence of genetic and rare problems, the rise in the burden of cancer, the developing applications of genetic testing, and the boom in focus on genetic testing in the area. For example, the Genetic and Rare Diseases (GARD) Information Center estimates that rare illnesses affect over 30 million individuals in the United States. Thus, due to the growing incidence of cancer and strategies taken by key regional players, the genetic testing market in North America is anticipated to increase significantly over the projection period.
Diagnostic testing is one of the best-known segments in the genetic testing market
By tests, the genetic testing market is fragmented into Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing, and Others. Diagnostic testing stands among the most prominent segments in the global genetic testing market. This is due to its pivotal position in identifying and dealing with hereditary conditions. Diagnostic assessments accurately and efficaciously monitor genetic predispositions to diseases, enabling early intervention and personalized treatment techniques. The developing emphasis on preventive healthcare drives the need for these tests as people and healthcare experts seek to mitigate fitness dangers and optimize patient consequences. Diagnostic testing's capability to empower informed choice-making underscores its significance in genetic testing.
Consumables have emerged as a major product category in the genetic testing market
By products, the genetic testing market is segmented into Consumables, Equipments, and Software & Services. Consumables have held one of the highest shares in the genetic testing market. This is owed to their critical position in sample collection, preparation, and analysis. Essential components like reagents, DNA extraction, and assay kits facilitate accurate and efficient genetic testing approaches. As the demand for genetic testing escalates, the want for reliable and exceptional consumables surges correspondingly. Their extensive use throughout numerous testing structures underscores their importance, making consumables a cornerstone of the global genetic testing market's increase and sustainability.
DNA sequencing is a significant component of the genetic testing market
By technology, the genetic testing market is categorized into PCR, DNA Sequencing, Microarrays, and Others. DNA sequencing is one of the notable segments in the global genetic testing market. This is due to its unheard-of potential to decode the genetic blueprint with precision and intensity. As technology advances, sequencing costs decline, making it more accessible for studies, diagnostics, and customized remedies. This complete approach enables the identity of genetic versions associated with diseases, facilitating early detection, risk evaluation, and tailor-made treatment strategies. DNA sequencing is pivotal in propelling innovation and progress within the genetic testing panorama with its transformative ability to release insights into human genetics.
Infectious diseases hold one of the leading segments of the global genetic testing market
By disease, the genetic testing market is classified into Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, and Others. The infectious diseases section is a distinguished force in the genetic testing market because of its crucial role in detecting and managing contagious pathogens. Genetic testing enables the rapid identity of microbial strains, aiding in ailment surveillance, outbreak management, and remedy optimization.
As infectious diseases pose global fitness threats, the demand for accurate and well-timed diagnostics escalates. Genetic tests offer precise insights into pathogen characteristics, facilitating focused interventions and public fitness measures. Infectious sickness testing emerges as a cornerstone of the genetic testing market with its potential to mitigate disease spread and enhance patient effects.
Hospitals and clinics segment holds a substantial share of the global market for genetic testing
The genetic testing market is categorized into Hospitals & Clinics, Diagnostic Laboratories, and Others based on end-users. The hospitals and clinics segment has one of the immense shares of the global genetic testing market. This is in general because of the required new child screening for genetic disorders and the rising incidence of cancer in various areas. In the U.S., about 98% of women deliver in hospitals. With access to superior diagnostic gadgets and professional clinical employees, hospitals and clinics are primary hubs for genetic testing services. Patients often search for testing within those settings for accurate diagnosis, personalized treatment plans, and genetic counseling. The enormous presence of hospitals and clinics internationally guarantees accessibility to genetic testing services, driving the segment's dominance in the market.
United States is presently the foremost market for genetic testing
By countries, the genetic testing market is divided into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, UAE). The United States is currently the leading market for genetic testing services. This is majorly due to the rising need for personalized genetic testing and an increase in chronic and genetic disorders.
According to the American Cancer Society's report, it is assessed that the number of new cancer incidences will reach 1,918,030 in the United States. The high engagement of critical players concerned with research activities for the invention of novel genetic testing products, along with the growing product permissions by the US Food and Drug Administration (FDA) and succeeding launches, are anticipated to drive market development in the United States.
Key Players
Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc., F Hoffmann-La Roche AG, Diasorin, Revvity Inc., and Thermo Fisher Scientific Inc. are the leading companies in the genetic testing market.
- In October 2023 - 23andMe Holding Co. announced a collaboration with GSK plc, allowing GSK to perform drug target discovery utilizing the 23andMe database.
Tests - Market breakup in 7 viewpoints:
1. Predictive Testing
2. Carrier Testing
3. Prenatal and Newborn Testing
4. Diagnostic Testing
5. Pharmacogenomic Testing
6. Nutrigenomic Testing
7. Others
Products - Market breakup in 3 viewpoints:
1. Consumables
2. Equipments
3. Software & Services
Technology - Market breakup in 4 viewpoints:
1. PCR
2. DNA Sequencing
3. Microarrays
4. Others
Disease - Market breakup in 6 viewpoints:
1. Cancer
2. Genetic Diseases
3. Cardiovascular Diseases
4. Rare Diseases
5. Infectious Diseases
6. Others
End-Users - Market breakup in 3 viewpoints:
1. Hospitals & Clinics
2. Diagnostic Laboratories
3. Others
Countries - Market breakup of 25 Countries:
1. North America
- 1.1 United States
- 1.2 Canada
2. Europe
- 2.1 France
- 2.2 Germany
- 2.3 Italy
- 2.4 Spain
- 2.5 United Kingdom
- 2.6 Belgium
- 2.7 Netherland
- 2.8 Turkey
3. Asia Pacific
- 3.1 China
- 3.2 Japan
- 3.3 India
- 3.4 South Korea
- 3.5 Thailand
- 3.6 Malaysia
- 3.7 Indonesia
- 3.8 Australia
- 3.9 New Zealand
4. Latin America
- 4.1 Brazil
- 4.2 Mexico
- 4.3 Argentina
5. Middle East & Africa
- 5.1 Saudi Arabia
- 5.2 UAE
- 5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Abbott Laboratories
2. Danaher Corporation (Cepheid Inc.)
3. Illumina Inc.
4. BioRad Laboratories Inc.
5. F Hoffmann-La Roche AG
6. Diasorin
7. Revvity Inc.
8. Thermo Fisher Scientific Inc.
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Genetic Testing Market
6. Market Share - Genetic Testing Market
- 6.1 By Type
- 6.2 By Product
- 6.3 By Technology
- 6.4 By Disease
- 6.5 By End User
- 6.6 By Countries
7. Type - Genetic Testing Market
- 7.1 Predictive Testing
- 7.2 Carrier Testing
- 7.3 Prenatal and Newborn Testing
- 7.4 Diagnostic Testing
- 7.5 Pharmacogenomic Testing
- 7.6 Nutrigenomic Testing
- 7.7 Others
8. Product-Genetic Testing Market
- 8.1 Consumables
- 8.2 Equipments
- 8.3 Software & Services
9. Technology - Genetic Testing Market
- 9.1 PCR
- 9.2 DNA Sequencing
- 9.3 Microarrays
- 9.4 Others
10. Disease - Genetic Testing Market
- 10.1 Cancer
- 10.2 Genetic Diseases
- 10.3 Cardiovascular Diseases
- 10.4 Rare Diseases
- 10.5 Infectious Diseases
- 10.6 Others
11. End User - Genetic Testing Market
- 11.1 Hospitals & Clinics
- 11.2 Diagnostic Laboratories
- 11.3 Others
12. Countries - Genetic Testing Market
- 12.1 North America
- 12.1.1 United States
- 12.1.2 Canada
- 12.2 Europe
- 12.2.1 France
- 12.2.2 Germany
- 12.2.3 Italy
- 12.2.4 Spain
- 12.2.5 United Kingdom
- 12.2.6 Belgium
- 12.2.7 Netherland
- 12.2.8 Turkey
- 12.3 Asia Pacific
- 12.3.1 China
- 12.3.2 Japan
- 12.3.3 India
- 12.3.4 South Korea
- 12.3.5 Thailand
- 12.3.6 Malaysia
- 12.3.7 Indonesia
- 12.3.8 Australia
- 12.3.9 New Zealand
- 12.4 Latin America
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.5 Middle East & Africa
- 12.5.1 Saudi Arabia
- 12.5.2 UAE
- 12.5.3 South Africa
13. Porter's Five Forces Analysis - Genetic Testing Market
- 13.1 Bargaining Power of Buyers
- 13.2 Bargaining Power of Suppliers
- 13.3 Degree of Rivalry
- 13.4 Threat of New Entrants
- 13.5 Threat of Substitutes
14. SWOT Analysis - Genetic Testing Market
- 14.1 Strength
- 14.2 Weakness
- 14.3 Opportunity
- 14.4 Threat
15. Key Players Analysis
- 15.1 Abbott Laboratories
- 15.1.1 Overview
- 15.1.2 Recent Development
- 15.1.3 Financial Insights
- 15.2 Danaher Corporation (Cepheid Inc.)
- 15.2.1 Overview
- 15.2.2 Recent Development
- 15.2.3 Financial Insights
- 15.3 Illumina Inc.
- 15.3.1 Overview
- 15.3.2 Recent Development
- 15.3.3 Financial Insights
- 15.4 BioRad Laboratories Inc.
- 15.4.1 Overview
- 15.4.2 Recent Development
- 15.4.3 Financial Insights
- 15.5 F Hoffmann-La Roche AG
- 15.5.1 Overview
- 15.5.2 Recent Development
- 15.5.3 Financial Insights
- 15.6 Diasorin
- 15.6.1 Overview
- 15.6.2 Recent Development
- 15.6.3 Financial Insights
- 15.7 Revvity Inc.
- 15.7.1 Overview
- 15.7.2 Recent Development
- 15.7.3 Financial Insights
- 15.8 Thermo Fisher Scientific Inc.
- 15.8.1 Overview
- 15.8.2 Recent Development
- 15.8.3 Financial Insights
List of Figures
- Figure-01: Global - Genetic Testing Market (Billion US$), 2019 - 2023
- Figure-02: Global - Forecast for Genetic Testing Market (Billion US$), 2024 - 2030
- Figure-03: Type - Predictive Testing Market (Million US$), 2019 - 2023
- Figure-04: Type - Forecast for Predictive Testing Market (Million US$), 2024 - 2030
- Figure-05: Type - Carrier Testing Market (Million US$), 2019 - 2023
- Figure-06: Type - Forecast for Carrier Testing Market (Million US$), 2024 - 2030
- Figure-07: Type - Prenatal and Newborn Testing Market (Million US$), 2019 - 2023
- Figure-08: Type - Forecast for Prenatal and Newborn Testing Market (Million US$), 2024 - 2030
- Figure-09: Type - Diagnostic Testing Market (Million US$), 2019 - 2023
- Figure-10: Type - Forecast for Diagnostic Testing Market (Million US$), 2024 - 2030
- Figure-11: Type - Pharmacogenomic Testing Market (Million US$), 2019 - 2023
- Figure-12: Type - Forecast for Pharmacogenomic Testing Market (Million US$), 2024 - 2030
- Figure-13: Type - Nutrigenomic Testing Market (Million US$), 2019 - 2023
- Figure-14: Type - Forecast for Nutrigenomic Testing Market (Million US$), 2024 - 2030
- Figure-15: Type - Others Market (Million US$), 2019 - 2023
- Figure-16: Type - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-17: Product - Consumables Market (Million US$), 2019 - 2023
- Figure-18: Product - Forecast for Consumables Market (Million US$), 2024 - 2030
- Figure-19: Product - Equipments Market (Million US$), 2019 - 2023
- Figure-20: Product - Forecast for Equipments Market (Million US$), 2024 - 2030
- Figure-21: Product - Software & Services Market (Million US$), 2019 - 2023
- Figure-22: Product - Forecast for Software & Services Market (Million US$), 2024 - 2030
- Figure-23: Technology - PCR Market (Million US$), 2019 - 2023
- Figure-24: Technology - Forecast for PCR Market (Million US$), 2024 - 2030
- Figure-25: Technology - DNA Sequencing Market (Million US$), 2019 - 2023
- Figure-26: Technology - Forecast for DNA Sequencing Market (Million US$), 2024 - 2030
- Figure-27: Technology - Microarrays Market (Million US$), 2019 - 2023
- Figure-28: Technology - Forecast for Microarrays Market (Million US$), 2024 - 2030
- Figure-29: Technology - Others Market (Million US$), 2019 - 2023
- Figure-30: Technology - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-31: Disease - Cancer Market (Million US$), 2019 - 2023
- Figure-32: Disease - Forecast for Cancer Market (Million US$), 2024 - 2030
- Figure-33: Disease - Genetic Diseases Market (Million US$), 2019 - 2023
- Figure-34: Disease - Forecast for Genetic Diseases Market (Million US$), 2024 - 2030
- Figure-35: Disease - Cardiovascular Diseases Market (Million US$), 2019 - 2023
- Figure-36: Disease - Forecast for Cardiovascular Diseases Market (Million US$), 2024 - 2030
- Figure-37: Disease - Rare Diseases Market (Million US$), 2019 - 2023
- Figure-38: Disease - Forecast for Rare Diseases Market (Million US$), 2024 - 2030
- Figure-39: Disease - Infectious Diseases Market (Million US$), 2019 - 2023
- Figure-40: Disease - Forecast for Infectious Diseases Market (Million US$), 2024 - 2030
- Figure-41: Disease - Others Market (Million US$), 2019 - 2023
- Figure-42: Disease - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-43: End User - Hospitals & Clinics Market (Million US$), 2019 - 2023
- Figure-44: End User - Forecast for Hospitals & Clinics Market (Million US$), 2024 - 2030
- Figure-45: End User - Diagnostic Laboratories Market (Million US$), 2019 - 2023
- Figure-46: End User - Forecast for Diagnostic Laboratories Market (Million US$), 2024 - 2030
- Figure-47: End User - Others Market (Million US$), 2019 - 2023
- Figure-48: End User - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-49: United States - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-50: United States - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-51: Canada - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-52: Canada - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-53: France - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-54: France - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-55: Germany - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-56: Germany - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-57: Italy - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-58: Italy - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-59: Spain - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-60: Spain - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-61: United Kingdom - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-62: United Kingdom - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-63: Belgium - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-64: Belgium - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-65: Netherland - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-66: Netherland - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-67: Turkey - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-68: Turkey - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-69: China - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-70: China - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-71: Japan - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-72: Japan - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-73: India - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-74: India - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-75: South Korea - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-76: South Korea - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-77: Thailand - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-78: Thailand - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-79: Malaysia - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-80: Malaysia - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-81: Indonesia - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-82: Indonesia - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-83: Australia - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-84: Australia - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-85: New Zealand - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-86: New Zealand - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-87: Brazil - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-88: Brazil - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-89: Mexico - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-90: Mexico - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-91: Argentina - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-92: Argentina - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-93: Saudi Arabia - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-94: Saudi Arabia - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-95: UAE - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-96: UAE - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-97: South Africa - Genetic Testing Market (Million US$), 2019 - 2023
- Figure-98: South Africa - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
- Figure-99: Abbott Laboratories - Global Revenue (Million US$), 2019 - 2023
- Figure-100: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-101: Danaher Corporation (Cepheid Inc.) - Global Revenue (Million US$), 2019 - 2023
- Figure-102: Danaher Corporation (Cepheid Inc.) - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-103: Illumina Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-104: Illumina Inc. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-105: BioRad Laboratories Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-106: BioRad Laboratories Inc. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-107: F Hoffmann-La Roche AG - Global Revenue (Million US$), 2019 - 2023
- Figure-108: F Hoffmann-La Roche AG - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-109: Diasorin - Global Revenue (Million US$), 2019 - 2023
- Figure-110: Diasorin - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-111: Revvity Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-112: Revvity Inc. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-113: Thermo Fisher Scientific Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-114: Thermo Fisher Scientific Inc. - Forecast for Global Revenue (Million US$), 2024 - 2030
List of Tables
- Table-01: Global - Genetic Testing Market Share by Type (Percent), 2019 - 2023
- Table-02: Global - Forecast for Genetic Testing Market Share by Type (Percent), 2024 - 2030
- Table-03: Global - Genetic Testing Market Share by Product (Percent), 2019 - 2023
- Table-04: Global - Forecast for Genetic Testing Market Share by Product (Percent), 2024 - 2030
- Table-05: Global - Genetic Testing Market Share by Technology (Percent), 2019 - 2023
- Table-06: Global - Forecast for Genetic Testing Market Share by Technology (Percent), 2024 - 2030
- Table-07: Global - Genetic Testing Market Share by Disease (Percent), 2019 - 2023
- Table-08: Global - Forecast for Genetic Testing Market Share by Disease (Percent), 2024 - 2030
- Table-09: Global - Genetic Testing Market Share by End User (Percent), 2019 - 2023
- Table-10: Global - Forecast for Genetic Testing Market Share by End User (Percent), 2024 - 2030
- Table-11: Global - Genetic Testing Market Share by Countries (Percent), 2019 - 2023
- Table-12: Global - Forecast for Genetic Testing Market Share by Countries (Percent), 2024 - 2030
